The Gemini Study was a 14‐week, open‐label, noncomparative, office‐based, multicenter
trial to evaluate single‐pill therapy in the treatment of concomitant hypertension and …

The AVALON study was a randomized, multicenter trial to assess the efficacy and safety of
coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia …

The recognition that hypertension and dyslipidemia coexist more often than would be
expected by chance and that their combination increases the risk of coronary heart disease …

Single‐pill amlodipine besylate/atorvastatin calcium (Caduet®, Pfizer Inc, NY, USA) is the
first therapy aimed at the simultaneous treatment of hypertension (HTN) and dyslipidaemia …

BACKGROUND: In order to prevent cardiovascular events, it is essential to effectively
manage overall risk of cardiovascular disease. However, despite guideline …

Endothelial dysfunction contributes to mechanisms of atherogenesis and its clinical
manifestations, including coronary heart disease. Cardiovascular risk factors have been …

This review describes the clinical profile and rationale for the development of a single-pill
formulation of the calcium channel blocker amlodipine besylate, a blood pressure-lowering …

This review describes the clinical profile and rationale for the development of a single-pill
formulation of the calcium channel blocker amlodipine besylate, a blood-pressure--lowering …

Статья посвящена проблеме лечения больных артериальной гипертонией и
дислипидемией. Обсуждаются вопросы приверженности к лечению …

Scan dinavian Cardiac Outcomes Trial)[1] по праву считается одним из важнейших
клинических испытаний последних лет. Как известно, цель данного исследования …